1 results  1 of 1 

1 Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
Wataru Yamagami, Nobuyuki Susumu, Takeshi Makabe, Kensuke Sakai, Hiroyuki Nomura, Fumio Kataoka, Akira Hirasawa, Kouji Banno, Daisuke Aoki
J Gynecol Oncol.2018;29(2):e21.  Published online 2018 January 2     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e21
      

 1 of 1